Revance Therapeutics (RVNC) Earnings (2014 - 2024)
Revance Therapeutics (RVNC) earnings from Mar 31, 2014 to Sep 30, 2024. The TTM Revance Therapeutics (RVNC) earnings is -$184M. You can adjust inflation or export chart.
Annual Earnings
Quarterly Earnings
Revance Therapeutics (RVNC) Earnings CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -55.48% |
| 3 Years TTM | -14.64% |
| 5 Years TTM | +3.58% |
| 10 Years TTM | +14.24% |
| All Time TTM | +13.18% |
Annual Earnings change of Revance Therapeutics (RVNC)
| Year | Earnings | Change |
|---|---|---|
| 2024 | -$129M | -60.27% |
| 2023 | -$324M | -9.10% |
| 2022 | -$356M | +26.70% |
| 2021 | -$281M | -0.28% |
| 2020 | -$282M | +76.94% |
| 2019 | -$159M | +11.83% |
| 2018 | -$143M | +18.23% |
| 2017 | -$121M | +35.08% |
| 2016 | -$89M | +21.49% |
| 2015 | -$73M | +16.78% |
| 2014 | -$63M | N/A |